跳至主要内容
临床试验/PACTR201612001903142
PACTR201612001903142招募中未知

Optimal dose intrathecal nalbuphine may improve markedly the duration analgesia with low side effect profile during anorectal surgery

Mansoura University hospitals0 个研究点目标入组 66 人开始时间: 2016年12月3日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Year(s) 至 70 Year(s)(—)
性别
All

入选标准

  • 1.Patients ASA I and II status
  • 2.Patients who will anorectal surgery like Hemmorrhoids, perianal fistula or tumors in the anal region will be included in this study.
  • 3.The age group is between 20 and 70 years old.

排除标准

  • 1.Refusal of the patient.
  • 2.Respiratory problems like chronic obstructive pulmonary disease (COPD) or asthmatic patients.
  • 3.Previous history of increased intracranial pressure.
  • 4.Renal or hepatic disease .
  • 5.Coagulopathy .
  • 6.Systemic or local Infection at the puncture site.
  • 7.Allergy to local anesthetics.
  • 8.ASA III and IV.
  • 9.History of opioid administration in the last hours .

研究者

发起方
Mansoura University hospitals

相似试验